News

Bone Fracture Drug Enters Clinical Trials

Written by Yourway | March 11, 2020

Broken bones in the elderly can pose a serious risk – one in three adults over age 60 that suffer a hip fracture die within a year. A drug discovered at Purdue University, NOV004, from Novosteo Inc. concentrates at the fracture site while reducing exposure to the rest of the body. The injectable drug may mean the difference between life and death for many older adults. Yourway supports clinical trials of every kind by offering central lab management and logistics, integrated project management, temperature control solutions, and biological sample shipments.